Further investigations revealed that CSRP2 could interact with p130Cas to suppress the activation of Rac1 and then inhibit EMT and metastasis of CRC via activating Hippo and inhibiting ERK and PAK-LIMK-cortactin signaling pathways. The gene discussed is RAC1; the disease is colorectal carcinoma.